Richard Pazdur (vis AACR)

FDA en­cour­ages in­clud­ing in­cur­able can­cer pa­tients in tri­als, re­gard­less of pri­or ther­a­pies

The FDA on Thurs­day called to in­clude those with in­cur­able can­cers (when there is no po­ten­tial for cure or for pro­longed/near nor­mal sur­vival) in ap­pro­pri­ate …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.